MedDataX Logo

Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

NCT ID: NCT00616772

Last Updated: 2018-07-02

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

682 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study is to test the effect and safety of once daily ABT-335 on the thickness of the lining of the carotid artery (a blood vessel to the brain) in patients with abnormal blood lipids who have optimal levels of low density lipoprotein cholesterol ("bad cholesterol") after taking atorvastatin.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia.

NCT00300430

Dyslipidemia Coronary Heart Disease Mixed Dyslipidemia
COMPLETED PHASE3

Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

NCT00300469

Mixed Dyslipidemia Coronary Heart Disease Dyslipidemia
COMPLETED PHASE3

Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

NCT00300456

Dyslipidemia Coronary Heart Disease Mixed Dyslipidemia
COMPLETED PHASE3

Safety and Efficacy Study Comparing ABT-335 Coadministered With Atorvastatin and Ezetimibe to Atorvastatin Coadministered With Ezetimibe in Subjects With Multiple Abnormal Lipid (Fat) Levels in the Blood

NCT00639158

Dyslipidemias Coronary Heart Disease Combined (Atherogenic) Dyslipidemia +1 more
COMPLETED PHASE3

A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

NCT00463606

Hypercholesterolemia Dyslipidemia
COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Coronary Heart Disease Dyslipidemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ABT-335 + Atorvastatin

ABT-335 (135 mg) and atorvastatin (up to 40 mg) once daily for 2 years.

Group Type EXPERIMENTAL

ABT-335

Intervention Type DRUG

Capsule

Atorvastatin

Intervention Type OTHER

Capsule

Placebo + Atorvastatin

Placebo and atorvastatin (up to 40 mg) once daily for 2 years.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Capsule

Atorvastatin

Intervention Type OTHER

Capsule

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ABT-335

Capsule

Intervention Type DRUG

Placebo

Capsule

Intervention Type DRUG

Atorvastatin

Capsule

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Choline fenofibrate Fenofibric acid

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with mixed dyslipidemia
* Qualifying cIMT thickness

Exclusion Criteria

* Patients with certain chronic or unstable medical conditions.
* Patients with unstable dose of medications or receiving coumadin, cyclosporine, or certain other medications
* Pregnant or lactating women or women intending to become pregnant
* Patients with diabetes mellitus that is poorly controlled
Minimum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AbbVie (prior sponsor, Abbott)

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maureen Kelly, MD

Role: STUDY_DIRECTOR

AbbVie

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Site Reference ID/Investigator# 6747

Chandler, Arizona, United States

Site Status

Site Reference ID/Investigator# 7089

Gilbert, Arizona, United States

Site Status

Site Reference ID/Investigator# 7097

Mesa, Arizona, United States

Site Status

Site Reference ID/Investigator# 26394

Phoenix, Arizona, United States

Site Status

Site Reference ID/Investigator# 6848

Scottsdale, Arizona, United States

Site Status

Site Reference ID/Investigator# 7059

Tempe, Arizona, United States

Site Status

Site Reference ID/Investigator# 7094

Tempe, Arizona, United States

Site Status

Site Reference ID/Investigator# 7098

Tempe, Arizona, United States

Site Status

Site Reference ID/Investigator# 25082

Anaheim, California, United States

Site Status

Site Reference ID/Investigator# 21347

Corona, California, United States

Site Status

Site Reference ID/Investigator# 21483

Garden Grove, California, United States

Site Status

Site Reference ID/Investigator# 21351

Huntington Beach, California, United States

Site Status

Site Reference ID/Investigator# 21346

Laguna Hills, California, United States

Site Status

Site Reference ID/Investigator# 21341

Long Beach, California, United States

Site Status

Site Reference ID/Investigator# 21342

Norwalk, California, United States

Site Status

Site Reference ID/Investigator# 21321

Santa Ana, California, United States

Site Status

Site Reference ID/Investigator# 26242

Tustin, California, United States

Site Status

Site Reference ID/Investigator# 15283

Arvada, Colorado, United States

Site Status

Site Reference ID/Investigator# 7085

Aurora, Colorado, United States

Site Status

Site Reference ID/Investigator# 6749

Denver, Colorado, United States

Site Status

Site Reference ID/Investigator# 7077

Denver, Colorado, United States

Site Status

Site Reference ID/Investigator# 7092

Golden, Colorado, United States

Site Status

Site Reference ID/Investigator# 7722

Littleton, Colorado, United States

Site Status

Site Reference ID/Investigator# 7721

Littleton, Colorado, United States

Site Status

Site Reference ID/Investigator# 11925

Aventura, Florida, United States

Site Status

Site Reference ID/Investigator# 15861

Boynton Beach, Florida, United States

Site Status

Site Reference ID/Investigator# 14422

Deerfield Beach, Florida, United States

Site Status

Site Reference ID/Investigator# 19281

Delray Beach, Florida, United States

Site Status

Site Reference ID/Investigator# 20881

Hollywood, Florida, United States

Site Status

Site Reference ID/Investigator# 20882

Kissimmee, Florida, United States

Site Status

Site Reference ID/Investigator# 19321

Melbourne, Florida, United States

Site Status

Site Reference ID/Investigator# 21353

Melbourne, Florida, United States

Site Status

Site Reference ID/Investigator# 18503

Melbourne, Florida, United States

Site Status

Site Reference ID/Investigator# 18841

Vero Beach, Florida, United States

Site Status

Site Reference ID/Investigator# 19961

Vero Beach, Florida, United States

Site Status

Site Reference ID/Investigator# 7166

West Palm Beach, Florida, United States

Site Status

Site Reference ID/Investigator# 6744

West Palm Beach, Florida, United States

Site Status

Site Reference ID/Investigator# 19301

Atlanta, Georgia, United States

Site Status

Site Reference ID/Investigator# 7051

Atlanta, Georgia, United States

Site Status

Site Reference ID/Investigator# 7109

Atlanta, Georgia, United States

Site Status

Site Reference ID/Investigator# 7326

Dawsonville, Georgia, United States

Site Status

Site Reference ID/Investigator# 7325

Decatur, Georgia, United States

Site Status

Site Reference ID/Investigator# 7057

Dunwoody, Georgia, United States

Site Status

Site Reference ID/Investigator# 7101

Dunwoody, Georgia, United States

Site Status

Site Reference ID/Investigator# 11324

Roswell, Georgia, United States

Site Status

Site Reference ID/Investigator# 6741

Roswell, Georgia, United States

Site Status

Site Reference ID/Investigator# 7103

Suwanee, Georgia, United States

Site Status

Site Reference ID/Investigator# 10761

Addison, Illinois, United States

Site Status

Site Reference ID/Investigator# 6748

Aurora, Illinois, United States

Site Status

Site Reference ID/Investigator# 6742

Aurora, Illinois, United States

Site Status

Site Reference ID/Investigator# 7128

Belleville, Illinois, United States

Site Status

Site Reference ID/Investigator# 7069

Chicago, Illinois, United States

Site Status

Site Reference ID/Investigator# 6849

Chicago, Illinois, United States

Site Status

Site Reference ID/Investigator# 6867

Chicago, Illinois, United States

Site Status

Site Reference ID/Investigator# 6751

Chicago, Illinois, United States

Site Status

Site Reference ID/Investigator# 6847

Chicago, Illinois, United States

Site Status

Site Reference ID/Investigator# 7049

Chicago, Illinois, United States

Site Status

Site Reference ID/Investigator# 7093

Gurnee, Illinois, United States

Site Status

Site Reference ID/Investigator# 6746

Hazel Crest, Illinois, United States

Site Status

Site Reference ID/Investigator# 6743

Melrose Park, Illinois, United States

Site Status

Site Reference ID/Investigator# 7090

Naperville, Illinois, United States

Site Status

Site Reference ID/Investigator# 6750

Oak Brook, Illinois, United States

Site Status

Site Reference ID/Investigator# 6788

Oak Park, Illinois, United States

Site Status

Site Reference ID/Investigator# 6927

Vernon Hills, Illinois, United States

Site Status

Site Reference ID/Investigator# 7076

Erlanger, Kentucky, United States

Site Status

Site Reference ID/Investigator# 8103

Bloomington, Minnesota, United States

Site Status

Site Reference ID/Investigator# 15121

Brooklyn Center, Minnesota, United States

Site Status

Site Reference ID/Investigator# 7050

Edina, Minnesota, United States

Site Status

Site Reference ID/Investigator# 7084

Edina, Minnesota, United States

Site Status

Site Reference ID/Investigator# 6784

City of Saint Peters, Missouri, United States

Site Status

Site Reference ID/Investigator# 6860

St Louis, Missouri, United States

Site Status

Site Reference ID/Investigator# 13182

St Louis, Missouri, United States

Site Status

Site Reference ID/Investigator# 14423

St Louis, Missouri, United States

Site Status

Site Reference ID/Investigator# 14541

St Louis, Missouri, United States

Site Status

Site Reference ID/Investigator# 6740

St Louis, Missouri, United States

Site Status

Site Reference ID/Investigator# 7053

St Louis, Missouri, United States

Site Status

Site Reference ID/Investigator# 7063

Henderson, Nevada, United States

Site Status

Site Reference ID/Investigator# 7070

Henderson, Nevada, United States

Site Status

Site Reference ID/Investigator# 7106

Las Vegas, Nevada, United States

Site Status

Site Reference ID/Investigator# 7518

Las Vegas, Nevada, United States

Site Status

Site Reference ID/Investigator# 7119

Las Vegas, Nevada, United States

Site Status

Site Reference ID/Investigator# 7129

Las Vegas, Nevada, United States

Site Status

Site Reference ID/Investigator# 7071

Cincinnati, Ohio, United States

Site Status

Site Reference ID/Investigator# 7100

Cincinnati, Ohio, United States

Site Status

Site Reference ID/Investigator# 14321

Cincinnati, Ohio, United States

Site Status

Site Reference ID/Investigator# 21355

Cincinnati, Ohio, United States

Site Status

Site Reference ID/Investigator# 7074

Cincinnati, Ohio, United States

Site Status

Site Reference ID/Investigator# 7065

Cincinnati, Ohio, United States

Site Status

Site Reference ID/Investigator# 7075

Dayton, Ohio, United States

Site Status

Site Reference ID/Investigator# 24802

Kettering, Ohio, United States

Site Status

Site Reference ID/Investigator# 7068

Mason, Ohio, United States

Site Status

Site Reference ID/Investigator# 7104

Bellaire, Texas, United States

Site Status

Site Reference ID/Investigator# 7060

Carrollton, Texas, United States

Site Status

Site Reference ID/Investigator# 15282

Dallas, Texas, United States

Site Status

Site Reference ID/Investigator# 6745

Dallas, Texas, United States

Site Status

Site Reference ID/Investigator# 7083

Dallas, Texas, United States

Site Status

Site Reference ID/Investigator# 7127

Dallas, Texas, United States

Site Status

Site Reference ID/Investigator# 7110

Dallas, Texas, United States

Site Status

Site Reference ID/Investigator# 21356

Deer Park, Texas, United States

Site Status

Site Reference ID/Investigator# 11923

Fort Worth, Texas, United States

Site Status

Site Reference ID/Investigator# 7321

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 21354

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 21358

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 26482

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 7079

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 7096

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 7126

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 8186

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 11323

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 7130

Houston, Texas, United States

Site Status

Site Reference ID/Investigator# 11924

Irving, Texas, United States

Site Status

Site Reference ID/Investigator# 13863

Irving, Texas, United States

Site Status

Site Reference ID/Investigator# 7099

McKinney, Texas, United States

Site Status

Site Reference ID/Investigator# 19121

New Braunfels, Texas, United States

Site Status

Site Reference ID/Investigator# 26244

Pearland, Texas, United States

Site Status

Site Reference ID/Investigator# 7105

Plano, Texas, United States

Site Status

Site Reference ID/Investigator# 7061

San Antonio, Texas, United States

Site Status

Site Reference ID/Investigator# 7320

San Antonio, Texas, United States

Site Status

Site Reference ID/Investigator# 7914

San Antonio, Texas, United States

Site Status

Site Reference ID/Investigator# 7058

San Antonio, Texas, United States

Site Status

Site Reference ID/Investigator# 18402

San Antonio, Texas, United States

Site Status

Site Reference ID/Investigator# 7052

San Antonio, Texas, United States

Site Status

Site Reference ID/Investigator# 7062

San Antonio, Texas, United States

Site Status

Site Reference ID/Investigator# 22947

San Antonio, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Davidson M, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Setze C, Carlson DM, Stolzenbach J. Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial. Cardiovasc Drugs Ther. 2012 Aug;26(4):349-58. doi: 10.1007/s10557-012-6395-z.

Reference Type RESULT
PMID: 22622962 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://rxabbvie.com

Related Info

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

M10-158

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides
NCT00812955 COMPLETED PHASE3
ABT-335 (Choline Fenofibrate) Reverse Cholesterol Transport (RCT) Study
NCT00673881 COMPLETED PHASE1/PHASE2
Evaluate Safety and Efficacy of ABT-335 in Combination With Rosuvastatin Calcium in Subjects With Multiple Abnormal Lipid Levels in the Blood
NCT00300482 COMPLETED PHASE3
A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia
NCT00491530 COMPLETED PHASE3
A Multiple-Dose Pharmacokinetic Interaction Study Between ABT-335, Atorvastatin and Ezetimibe
NCT00681525 COMPLETED PHASE1
Evaluation of Atorvastatin Treatment on Carotid Plaque.
NCT00343655 TERMINATED PHASE3
A Study in People With High Cholesterol
NCT00133380 COMPLETED PHASE2
Study of Trilipix Effects on Lipids and Arteries
NCT01025492 TERMINATED PHASE4
A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia
NCT01779453 COMPLETED PHASE2
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
NCT00163163 COMPLETED PHASE3
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia
NCT06238466 ACTIVE_NOT_RECRUITING PHASE1
Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)
NCT00442845 COMPLETED PHASE4
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
NCT03051100 COMPLETED PHASE2
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
NCT00990808 COMPLETED PHASE1
Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
NCT00408382 COMPLETED PHASE4
A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1)
NCT01370590 COMPLETED PHASE3
The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study
NCT01053065 COMPLETED NA
Investigating the Effects of Lipid-therapy Intensification With Alirocumab on Endothelial Function, Carotid Arteries, Lipoprotein Particle Subfractions, Inflammation and Post-prandial Lipemia
NCT03559309 TERMINATED PHASE4
A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia
NCT03381287 COMPLETED PHASE1/PHASE2
Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
NCT00689442 COMPLETED PHASE2
A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
NCT05683340 COMPLETED PHASE3
A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease
NCT00134173 COMPLETED PHASE3
Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin.
NCT00134238 TERMINATED PHASE3
A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
NCT00530946 COMPLETED PHASE3
Randomized Study of Obicetrapib in Combination With Ezetimibe
NCT04770389 COMPLETED PHASE2